At Cell Constructs, we are committed to innovating new human keratin-based healthcare technologies in order to provide patients and their healthcare providers with leading-edge active wound care solutions. Our scientists are discovering new formulations to increase and release the power of human keratin for use in current and new applications and new markets.
Our research philosophy is focused on wound care technologies to advance healing, as well as exploring new approaches to help physicians help their patients.
ProgenaMatrix is currently undergoing a 510k premarket review by FDA for dry, light and moderately exuding partial and full thickness wounds. Not available for sale or other clinical use.